TINF2 Gene Mutation Analysis
The TINF2 gene is located on the long (q) arm of chromosome 14 at position 12 and encodes TERF1-interacting nuclear factor 2 (TINF2), which is a part of the shelterin protein complex which is important in maintaining telomeres. Telomeres are regions of repeating DNA sequences at the ends of chromosomes that protect the chromosome from deterioration and prevent binding with other chromosomes. Without the protective activity of shelterin complex, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends gets inappropriately processed by DNA repair pathways. Mutations in the TINF2 are responsible for 12-20% of Dyskeratosis congenita cases, including severe forms of this disorder named Revesz syndrome and Hoyeraal-Hreidarsson syndrome (HHS).
Dyskeratosis congenital (DC) is characterized by the triad of; lacy skin pigmentation of the upper chest and neck, dystrophic nails, and oral leukoplakia. Other features may include: epiphora, developmental delay, pulmonary fibrosis, short stature, poor dentition, esophageal stricture, premature hair loss and an increased risk for bone marrow failure, leukemia and a variety of cancers. Most of the TINF2 gene mutations that cause result in dysfunction of the shelterin complex, leading to reduced telomere length. Shortened telomeres can result further genetic damage, causing the cell to stop dividing or to undergo apoptosis. As a result, people with DC may experience a variety of problems affecting quickly dividing cells in the body such as cells of the nail beds, hair follicles, skin, lining of the mouth (oral mucosa), and bone marrow. Breakage and instability of chromosomes resulting from inadequate telomere maintenance may lead to genetic changes that allow cells to divide in an uncontrolled way, resulting in the development of cancer in some people with DC.
Hoyeraal-Hreidarsson (HH) and Revesz Syndromes are severe forms of DC. HH is characterized by microcephaly, growth and mental retardation, spastic paresis, ataxia and immunodeficiency. Revesz syndrome is characterized by bilateral retinal exudative retinopathy and intracranial calcifications. Generally, in all forms of DC, telomere protection or maintenance is defective.
- Diagnostic confirmation of dyskeratosis congenita
- For the carrier testing in family members at risk
- To confirm that a potential hematopoietic stem cell transplant donor is not affected
Positive: Mutation or pathogenic variant in TINF2 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.
Negative: No mutation or pathogenic variant in TINF2 gene.
Negative for mutation or pathogenic variant in TINF2 gene
Whole blood, Cultured cells, Skin biopsy.
Stability (whole blood)
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unacceptable
- Case Rep Dermatol. 2015;7: 212-9. [PMID: 26351433]
- Clin Genet. 2012;81: 470-8. PMID: 21477109
- Int J Dent Hyg. 2010;8: 68-74. [PMID: 20096085]
- Biochim Biophys Acta. 2009;1792: 371-9. [PMID: 19419704]
- Br J Haematol. 2009;145: 164-72. [PMID: 19208095]
- Genetics Home Reference. Available: https://ghr.nlm.nih.gov/gene/TINF2#conditions
- Revy, P., & Touzot, F. (2016). The Immunologic Complications and Genetic Origins of Telomere Disorders. Encyclopedia of Immunobiology, vol 5- 451–457. doi:10.1016/b978-0-12-374279-7.18007-5